[
  {
    "title": "普洛药业(000739.SZ)：与先声药业签订战略合作框架协议、开展CDMO项目的长期合作",
    "href": "http://stock.jrj.com.cn/2023/01/03171937255662.shtml",
    "datetime": "2023-01-03 17:19:40",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：年初以来累获政府补助1.5亿元",
    "href": "http://stock.jrj.com.cn/2022/12/28182037243832.shtml",
    "datetime": "2022-12-28 18:20:47",
    "code": "000739"
  },
  {
    "title": "普洛药业控股股东横店控股质押5500万股 用于融资",
    "href": "http://stock.jrj.com.cn/2022/11/16211137144941.shtml",
    "datetime": "2022-11-16 21:11:08",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：控股股东质押5500万股",
    "href": "http://stock.jrj.com.cn/2022/11/16155537143628.shtml",
    "datetime": "2022-11-16 15:55:29",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：完成回购 累计耗资约2亿元回购919.99万股",
    "href": "http://stock.jrj.com.cn/2022/11/07181137117820.shtml",
    "datetime": "2022-11-07 18:11:27",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：截至10月底已累计回购0.78%股份",
    "href": "http://stock.jrj.com.cn/2022/11/01201037104517.shtml",
    "datetime": "2022-11-01 20:10:17",
    "code": "000739"
  },
  {
    "title": "普洛药业：预计明年资本开支在16-17亿左右",
    "href": "http://stock.jrj.com.cn/2022/10/21183937074146.shtml",
    "datetime": "2022-10-21 18:39:21",
    "code": "000739"
  },
  {
    "title": "普洛药业2022年前三季度净利6.57亿同比下滑13.76% 投资收益减少",
    "href": "http://stock.jrj.com.cn/2022/10/19183237067698.shtml",
    "datetime": "2022-10-19 18:32:20",
    "code": "000739"
  },
  {
    "title": "普洛药业：前三季度净利润6.57亿元 同比降13.76%",
    "href": "http://stock.jrj.com.cn/2022/10/19170837067289.shtml",
    "datetime": "2022-10-19 17:08:43",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：上海创智拟吸收合并上海裕缘",
    "href": "http://stock.jrj.com.cn/2022/10/19164937067184.shtml",
    "datetime": "2022-10-19 16:49:10",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)第三季度扣非净利润2.45亿元、同比增长44.21%",
    "href": "http://stock.jrj.com.cn/2022/10/19164837067187.shtml",
    "datetime": "2022-10-19 16:48:36",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：吸入用乙酰半胱氨酸溶液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/09/20163737008192.shtml",
    "datetime": "2022-09-20 16:37:17",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：酒石酸美托洛尔注射液获批上市",
    "href": "http://stock.jrj.com.cn/2022/09/05170436974116.shtml",
    "datetime": "2022-09-05 17:04:10",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)截至8月底已累计回购919.99万股",
    "href": "http://stock.jrj.com.cn/2022/09/01174336963566.shtml",
    "datetime": "2022-09-01 17:43:34",
    "code": "000739"
  },
  {
    "title": "A股异动 | 普洛药业涨5% 上半年业绩符预期 Q2单季收入创历史新高",
    "href": "http://stock.jrj.com.cn/2022/07/28140436850121.shtml",
    "datetime": "2022-07-28 14:04:38",
    "code": "000739"
  },
  {
    "title": "普洛药业2022年上半年净利4.37亿同比下滑21% 停工损失增加",
    "href": "http://stock.jrj.com.cn/2022/07/27201336848081.shtml",
    "datetime": "2022-07-27 20:13:10",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：上半年净利降21.04%至4.37亿元",
    "href": "http://stock.jrj.com.cn/2022/07/27174036847523.shtml",
    "datetime": "2022-07-27 17:40:47",
    "code": "000739"
  },
  {
    "title": "普洛药业全资子公司拟投资5100万设立孙公司宁波普邦生物科技有限公司 持股51%",
    "href": "http://stock.jrj.com.cn/2022/07/25223136841577.shtml",
    "datetime": "2022-07-25 22:31:06",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：普洛生物出资5100万元设立宁波普邦生物、注册资本1亿元",
    "href": "http://stock.jrj.com.cn/2022/07/25191336840969.shtml",
    "datetime": "2022-07-25 19:13:29",
    "code": "000739"
  },
  {
    "title": "普洛药业副总经理汤二庆辞职 2021年薪酬为81万",
    "href": "http://stock.jrj.com.cn/2022/07/15201036817134.shtml",
    "datetime": "2022-07-15 20:10:50",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：头孢克肟片和头孢克肟颗粒拟中选第七批国采",
    "href": "http://stock.jrj.com.cn/2022/07/13165836807700.shtml",
    "datetime": "2022-07-13 16:58:03",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)琥珀酸美托洛尔缓释片拟中选第七批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2022/07/12203536804676.shtml",
    "datetime": "2022-07-12 20:35:55",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：截至6月底已累计回购756.82万股",
    "href": "http://stock.jrj.com.cn/2022/07/01163136775470.shtml",
    "datetime": "2022-07-01 16:31:28",
    "code": "000739"
  },
  {
    "title": "普洛药业5名股东合计增持31万股 耗资合计约620.93万 2021年公司净利9.56亿",
    "href": "http://stock.jrj.com.cn/2022/06/27205336762596.shtml",
    "datetime": "2022-06-27 20:53:03",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：部分董事和高管已合计买入31万股",
    "href": "http://stock.jrj.com.cn/2022/06/27162136761303.shtml",
    "datetime": "2022-06-27 16:21:48",
    "code": "000739"
  },
  {
    "title": "普洛药业拟投资3000万设立创业投资基金 持股10%",
    "href": "http://stock.jrj.com.cn/2022/06/23201036754390.shtml",
    "datetime": "2022-06-23 20:10:52",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：拟出资3000万元参设医疗创投基金",
    "href": "http://stock.jrj.com.cn/2022/06/23163836753353.shtml",
    "datetime": "2022-06-23 16:38:13",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：截至5月底已累计回购562.11万股",
    "href": "http://stock.jrj.com.cn/2022/06/02161036700552.shtml",
    "datetime": "2022-06-02 16:10:00",
    "code": "000739"
  },
  {
    "title": "普洛药业聘任何春、蔡磊均为公司高级副总经理 2021年公司净利9.56亿",
    "href": "http://stock.jrj.com.cn/2022/05/18185236659629.shtml",
    "datetime": "2022-05-18 18:52:55",
    "code": "000739"
  },
  {
    "title": "A股异动 | 普洛药业涨7% 2名高管合计增持11万股",
    "href": "http://stock.jrj.com.cn/2022/05/18095336657628.shtml",
    "datetime": "2022-05-18 09:53:14",
    "code": "000739"
  },
  {
    "title": "普洛药业2名高管合计增持11万股 耗资约255.64万 2021年公司净利9.56亿",
    "href": "http://stock.jrj.com.cn/2022/05/17201136656401.shtml",
    "datetime": "2022-05-17 20:11:06",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：董事长、总经理5月17日合计增持11万股",
    "href": "http://stock.jrj.com.cn/2022/05/17174936655728.shtml",
    "datetime": "2022-05-17 17:49:10",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：5月17日首次回购208.31万股",
    "href": "http://stock.jrj.com.cn/2022/05/17174836655730.shtml",
    "datetime": "2022-05-17 17:48:04",
    "code": "000739"
  },
  {
    "title": "【龙虎榜】普洛药业5月16日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/16180136652030.shtml",
    "datetime": "2022-05-16 18:01:24",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟以2亿元-4亿元回购公司股份，回购价格不超过30元/股",
    "href": "http://stock.jrj.com.cn/2022/05/10112836617899.shtml",
    "datetime": "2022-05-10 11:28:15",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟2亿元-4亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/05/09183836608906.shtml",
    "datetime": "2022-05-09 18:38:57",
    "code": "000739"
  },
  {
    "title": "【龙虎榜】普洛药业5月9日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/09180136608320.shtml",
    "datetime": "2022-05-09 18:01:31",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟斥资2亿至4亿元回购股份",
    "href": "http://stock.jrj.com.cn/2022/05/06141036579646.shtml",
    "datetime": "2022-05-06 14:10:30",
    "code": "000739"
  },
  {
    "title": "A股异动丨普洛药业涨逾4% 拟2亿元-4亿元回购股份",
    "href": "http://stock.jrj.com.cn/2022/05/06095036577248.shtml",
    "datetime": "2022-05-06 09:50:26",
    "code": "000739"
  },
  {
    "title": "普洛药业等拟回购股份",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/06073636576413.shtml",
    "datetime": "2022-05-06 07:36:49",
    "code": "000739"
  },
  {
    "title": "普洛药业2022年第一季度净利1.52亿同比下滑29.96% 投资收益减少",
    "href": "http://stock.jrj.com.cn/2022/05/03153336543722.shtml",
    "datetime": "2022-05-03 15:33:07",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：一季度净利降29.96%至1.52亿元",
    "href": "http://stock.jrj.com.cn/2022/04/26163836476079.shtml",
    "datetime": "2022-04-26 16:38:29",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：注射用氟氯西林钠获批上市",
    "href": "http://stock.jrj.com.cn/2022/04/14160136334933.shtml",
    "datetime": "2022-04-14 16:01:44",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：左氧氟沙星片通过WHO的PQ认证",
    "href": "http://stock.jrj.com.cn/2022/04/07180136268733.shtml",
    "datetime": "2022-04-07 18:01:22",
    "code": "000739"
  },
  {
    "title": "【龙虎榜】普洛药业3月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/21180234856560.shtml",
    "datetime": "2022-03-21 18:02:02",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：获相关新冠口服药物在指定区域内的非独家许可",
    "href": "http://stock.jrj.com.cn/2022/03/18160034845162.shtml",
    "datetime": "2022-03-18 16:00:50",
    "code": "000739"
  },
  {
    "title": "普洛药业：MPP授权获许可区域不包括中国",
    "href": "http://stock.jrj.com.cn/2022/03/18155434845135.shtml",
    "datetime": "2022-03-18 15:54:49",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)临近午盘收盘拉升涨停 获允许生产辉瑞Paxlovid成分原料药",
    "href": "http://stock.jrj.com.cn/2022/03/17124734838463.shtml",
    "datetime": "2022-03-17 12:47:53",
    "code": "000739"
  },
  {
    "title": "普洛药业2021年净利9.56亿同比增长17% 董事长祝方猛薪酬240万",
    "href": "http://stock.jrj.com.cn/2022/03/09223334637875.shtml",
    "datetime": "2022-03-09 22:33:29",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：拟使用不超15亿元自有闲置资金进行理财投资",
    "href": "http://stock.jrj.com.cn/2022/03/09214934631314.shtml",
    "datetime": "2022-03-09 21:49:25",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：第一期员工持股计划存续期展期24个月",
    "href": "http://stock.jrj.com.cn/2022/03/09214834631172.shtml",
    "datetime": "2022-03-09 21:48:04",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：2021年度净利升17.00%至9.56亿元 拟10派2.85元",
    "href": "http://stock.jrj.com.cn/2022/03/09190534593028.shtml",
    "datetime": "2022-03-09 19:05:06",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：控股股东解除质押1.56亿股",
    "href": "http://stock.jrj.com.cn/2022/03/03155834516027.shtml",
    "datetime": "2022-03-03 15:58:45",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：子公司注射用头孢呋辛钠(0.25g，0.75g)通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2022/02/14163434344792.shtml",
    "datetime": "2022-02-14 16:34:46",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：第一期员工持股计划存续期将于2022年5月28日届满",
    "href": "http://stock.jrj.com.cn/2021/11/16160533860352.shtml",
    "datetime": "2021-11-16 16:05:26",
    "code": "000739"
  },
  {
    "title": "A股异动 | 普洛药业(000739.SZ)盘中涨停 子公司原料药头孢克肟获CEP证书",
    "href": "http://stock.jrj.com.cn/2021/11/10095533830741.shtml",
    "datetime": "2021-11-10 09:55:56",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：子公司头孢克肟原料药获得CEP证书",
    "href": "http://stock.jrj.com.cn/2021/11/09155733827718.shtml",
    "datetime": "2021-11-09 15:57:44",
    "code": "000739"
  },
  {
    "title": "【龙虎榜】普洛药业10月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/10/22180233734550.shtml",
    "datetime": "2021-10-22 18:02:15",
    "code": "000739"
  },
  {
    "title": "400亿医药股普洛药业一字跌停，前三季度净利增长20.95%，谢治宇减仓",
    "href": "http://stock.jrj.com.cn/2021/10/22103433731810.shtml",
    "datetime": "2021-10-22 10:34:32",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：第三季度净利升4.03%至2.09亿元",
    "href": "http://stock.jrj.com.cn/2021/10/21173633728008.shtml",
    "datetime": "2021-10-21 17:36:27",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：子公司获得关于琥珀酸美托洛尔缓释片的药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/10/12212733681136.shtml",
    "datetime": "2021-10-12 21:27:12",
    "code": "000739"
  },
  {
    "title": "普洛药业：子公司头孢克肟颗粒获药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/09/28172133531167.shtml",
    "datetime": "2021-09-28 17:21:43",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：子公司头孢克肟颗粒获批上市",
    "href": "http://stock.jrj.com.cn/2021/09/28170733531040.shtml",
    "datetime": "2021-09-28 17:07:27",
    "code": "000739"
  },
  {
    "title": "普洛药业在美国投资4700万美元设立CDMO研发中心",
    "href": "http://stock.jrj.com.cn/2021/08/26212033327020.shtml",
    "datetime": "2021-08-26 21:20:42",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟在美国波士顿投资设立CDMO研发中心",
    "href": "http://stock.jrj.com.cn/2021/08/26163133324508.shtml",
    "datetime": "2021-08-26 16:31:10",
    "code": "000739"
  },
  {
    "title": "普洛药业2021年半年度净利5.53亿元 同比净利增加28.86%",
    "href": "http://stock.jrj.com.cn/2021/08/18180533274830.shtml",
    "datetime": "2021-08-18 18:05:09",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)半年度净利润5.53亿元 同比增长28.86%",
    "href": "http://stock.jrj.com.cn/2021/08/18163833274024.shtml",
    "datetime": "2021-08-18 16:38:45",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：普洛生物与联邦制药签订合作框架协议 以开展兽药领域合作",
    "href": "http://stock.jrj.com.cn/2021/07/26162833152535.shtml",
    "datetime": "2021-07-26 16:28:28",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：左氧氟沙星原料药获得CEP证书",
    "href": "http://stock.jrj.com.cn/2021/07/20201533125713.shtml",
    "datetime": "2021-07-20 20:15:48",
    "code": "000739"
  },
  {
    "title": "普洛药业：与中控技术达成战略合作，推动智能制造产业布局",
    "href": "http://stock.jrj.com.cn/2021/07/13152733089187.shtml",
    "datetime": "2021-07-13 15:27:49",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：与中控技术签订战略合作协议",
    "href": "http://stock.jrj.com.cn/2021/07/12222633084686.shtml",
    "datetime": "2021-07-12 22:26:00",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：子公司的乌苯美司胶囊获批上市",
    "href": "http://stock.jrj.com.cn/2021/07/01202933028943.shtml",
    "datetime": "2021-07-01 20:29:24",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：注射用头孢他啶拟中选第五批全国药品集采",
    "href": "http://stock.jrj.com.cn/2021/06/23171532983639.shtml",
    "datetime": "2021-06-23 17:15:41",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：注射用头孢他啶通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2021/06/10202732906844.shtml",
    "datetime": "2021-06-10 20:27:13",
    "code": "000739"
  },
  {
    "title": "普洛药业：公司对确定订单采取了锁汇的方式来规避汇率波动对业绩产生的风险人民币升值对公司影响可控",
    "href": "http://stock.jrj.com.cn/2021/06/01163132857140.shtml",
    "datetime": "2021-06-01 16:31:40",
    "code": "000739"
  },
  {
    "title": "普洛药业：公司目前生产经营正常",
    "href": "http://stock.jrj.com.cn/2021/06/01163132857138.shtml",
    "datetime": "2021-06-01 16:31:31",
    "code": "000739"
  },
  {
    "title": "【龙虎榜】普洛药业5月27日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/27180132830921.shtml",
    "datetime": "2021-05-27 18:01:50",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)2020年度权益分派10派2.43元 股权登记日为4月28日",
    "href": "http://stock.jrj.com.cn/2021/04/22174332424374.shtml",
    "datetime": "2021-04-22 17:43:33",
    "code": "000739"
  },
  {
    "title": "普洛药业2021年第一季度净利增长40.34% 理财收益增加",
    "href": "http://stock.jrj.com.cn/2021/04/20154632409940.shtml",
    "datetime": "2021-04-20 15:46:40",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)一季度净利润升40.34%至2.17亿元",
    "href": "http://stock.jrj.com.cn/2021/04/19173432402893.shtml",
    "datetime": "2021-04-19 17:34:07",
    "code": "000739"
  },
  {
    "title": "普洛药业：与济民可信签署战略合作框架协议 有利于推进研产销全方位合作平台建设",
    "href": "http://stock.jrj.com.cn/2021/03/17203532153062.shtml",
    "datetime": "2021-03-17 20:35:06",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)与江西济民可信集团签订战略合作框架协议",
    "href": "http://stock.jrj.com.cn/2021/03/17155232151185.shtml",
    "datetime": "2021-03-17 15:52:26",
    "code": "000739"
  },
  {
    "title": "A股异动 | 普洛药业(000739.SZ)涨超4% 2020年度纯利同比增长47.58%",
    "href": "http://stock.jrj.com.cn/2021/03/12140832115048.shtml",
    "datetime": "2021-03-12 14:08:34",
    "code": "000739"
  },
  {
    "title": "美中不足！普洛药业年报业绩连续三年大增 研发费用和毛利率却“双降”",
    "href": "http://stock.jrj.com.cn/2021/03/12080232113905.shtml",
    "datetime": "2021-03-12 08:02:00",
    "code": "000739"
  },
  {
    "title": "普洛药业2020年净利8.17亿增长47.58%原料药业务稳健增长 董事长祝方猛薪酬200万",
    "href": "http://stock.jrj.com.cn/2021/03/11195332110754.shtml",
    "datetime": "2021-03-11 19:53:39",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：拟使用不超15亿元自有闲置资金进行理财产品的投资",
    "href": "http://stock.jrj.com.cn/2021/03/11164032109720.shtml",
    "datetime": "2021-03-11 16:40:14",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)2020年度净利润升47.58%至8.17亿元 拟10派2.43元",
    "href": "http://stock.jrj.com.cn/2021/03/11163832109700.shtml",
    "datetime": "2021-03-11 16:38:27",
    "code": "000739"
  },
  {
    "title": "【龙虎榜】普洛药业2月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/02/23180132013374.shtml",
    "datetime": "2021-02-23 18:01:33",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：盐酸美金刚片获批上市",
    "href": "http://stock.jrj.com.cn/2021/02/08155731870306.shtml",
    "datetime": "2021-02-08 15:57:10",
    "code": "000739"
  },
  {
    "title": "普洛药业2020年预计净利7.8亿-8.5亿增长40.95%-53.6% 原料药销售毛利同比增加",
    "href": "http://stock.jrj.com.cn/2021/01/25204831768589.shtml",
    "datetime": "2021-01-25 20:48:26",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：拟与上海交通大学共建药物创新联合研究中心",
    "href": "http://stock.jrj.com.cn/2021/01/18181231716372.shtml",
    "datetime": "2021-01-18 18:12:17",
    "code": "000739"
  },
  {
    "title": "普洛药业(000739.SZ)：原料药硫酸氢氯吡格雷II型获得CEP证书",
    "href": "http://stock.jrj.com.cn/2020/12/23154631553985.shtml",
    "datetime": "2020-12-23 15:46:07",
    "code": "000739"
  },
  {
    "title": "普洛药业与浙江工业大学签订合作框架协议及技术开发（委托）合同",
    "href": "http://stock.jrj.com.cn/2020/11/19215731318750.shtml",
    "datetime": "2020-11-19 21:57:13",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟与浙工大共建联合研究中心 有利于公司在生物工程领域业务拓展布局",
    "href": "http://stock.jrj.com.cn/2020/11/19184131317686.shtml",
    "datetime": "2020-11-19 18:41:49",
    "code": "000739"
  },
  {
    "title": "普洛药业董事长祝方猛增持10.17万股 耗资202.51万元",
    "href": "http://stock.jrj.com.cn/2020/11/02194731202339.shtml",
    "datetime": "2020-11-02 19:47:23",
    "code": "000739"
  },
  {
    "title": "普洛药业：高活性实验室和生产线的总投资额大概会在4亿元左右",
    "href": "http://stock.jrj.com.cn/2020/10/23102331114555.shtml",
    "datetime": "2020-10-23 10:23:34",
    "code": "000739"
  },
  {
    "title": "普洛药业2020年前三季度净利6.3亿增长45.99% 毛利同比增加",
    "href": "http://stock.jrj.com.cn/2020/10/21182631101826.shtml",
    "datetime": "2020-10-21 18:26:49",
    "code": "000739"
  },
  {
    "title": "普洛药业：前三季度实现净利6.3亿元 同比增逾四成",
    "href": "http://stock.jrj.com.cn/2020/10/21174031101491.shtml",
    "datetime": "2020-10-21 17:40:54",
    "code": "000739"
  },
  {
    "title": "普洛药业：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/09/27233030845279.shtml",
    "datetime": "2020-09-27 23:30:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：索法地尔项目目前已经完成Ⅱ期临床试验正在准备Ⅲ临床试验中",
    "href": "http://stock.jrj.com.cn/2020/09/21102130800865.shtml",
    "datetime": "2020-09-21 10:21:16",
    "code": "000739"
  },
  {
    "title": "普洛药业拟投资设立上海普洛创智医药科技有限公司 注册资本1500万",
    "href": "http://stock.jrj.com.cn/2020/09/02204230662750.shtml",
    "datetime": "2020-09-02 20:42:22",
    "code": "000739"
  },
  {
    "title": "康希诺生物新冠疫苗在俄罗斯启动Ⅲ期临床试验 普洛药业拟设立子公司深入CDMO业务 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/09/02182830662259.shtml",
    "datetime": "2020-09-02 18:28:37",
    "code": "000739"
  },
  {
    "title": "普洛药业拟在上海自贸区设立子公司 提供CDMO服务",
    "href": "http://stock.jrj.com.cn/2020/09/02182630662258.shtml",
    "datetime": "2020-09-02 18:26:21",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟在上海自贸区设立子公司 为国内外客户提供CDMO服务",
    "href": "http://stock.jrj.com.cn/2020/09/02174530662059.shtml",
    "datetime": "2020-09-02 17:45:00",
    "code": "000739"
  },
  {
    "title": "普洛药业拟在上海自贸区设立子公司 持续深入打造公司CDMO业务研发实力",
    "href": "http://stock.jrj.com.cn/2020/09/02174130662005.shtml",
    "datetime": "2020-09-02 17:41:26",
    "code": "000739"
  },
  {
    "title": "[普洛药业]2019年度中国医药工业百强榜重磅出炉:普洛药业位列第46名",
    "href": "http://stock.jrj.com.cn/2020/08/30000030808982.shtml",
    "datetime": "2020-08-30 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛药业制剂生产线首获WHO批准 国际化战略行稳致远",
    "href": "http://stock.jrj.com.cn/2020/08/20000030808981.shtml",
    "datetime": "2020-08-20 00:00:00",
    "code": "000739"
  },
  {
    "title": "【龙虎榜】普洛药业8月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/18180230531147.shtml",
    "datetime": "2020-08-18 18:02:23",
    "code": "000739"
  },
  {
    "title": "普洛药业2020年上半年净利4.29亿增长52.93% 制剂市场营销费用下降",
    "href": "http://stock.jrj.com.cn/2020/08/18140130529326.shtml",
    "datetime": "2020-08-18 14:01:02",
    "code": "000739"
  },
  {
    "title": "普洛药业：出口制剂车间通过GMP审计",
    "href": "http://stock.jrj.com.cn/2020/08/16180430507025.shtml",
    "datetime": "2020-08-16 18:04:02",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛药业支持亚洲制药产业大会,竞展企业风采",
    "href": "http://stock.jrj.com.cn/2020/08/06000030808980.shtml",
    "datetime": "2020-08-06 00:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业原料药收入持续增长 上半年净利预增45%—55%",
    "href": "http://stock.jrj.com.cn/2020/07/03071030129405.shtml",
    "datetime": "2020-07-03 07:10:14",
    "code": "000739"
  },
  {
    "title": "【龙虎榜】普洛药业7月2日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/02180130124031.shtml",
    "datetime": "2020-07-02 18:01:21",
    "code": "000739"
  },
  {
    "title": "上半年净利预增45%-55% 普洛药业涨停",
    "href": "http://stock.jrj.com.cn/2020/07/02100430119454.shtml",
    "datetime": "2020-07-02 10:04:20",
    "code": "000739"
  },
  {
    "title": "快讯：普洛药业急速拉升9.43% 主力资金净流入1329.65万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/02094130119048.shtml",
    "datetime": "2020-07-02 09:41:41",
    "code": "000739"
  },
  {
    "title": "普洛药业：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/02020030115102.shtml",
    "datetime": "2020-07-02 02:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：上半年净利预增45.28%-55.25%",
    "href": "http://stock.jrj.com.cn/2020/07/01195230113334.shtml",
    "datetime": "2020-07-01 19:52:55",
    "code": "000739"
  },
  {
    "title": "普洛药业：普洛康裕公司原料药盐酸美金刚获相关认证 具备向日本市场供应资质",
    "href": "http://stock.jrj.com.cn/2020/05/20164129722234.shtml",
    "datetime": "2020-05-20 16:41:02",
    "code": "000739"
  },
  {
    "title": "普洛药业：孙公司“安徽生物”通过EDQM官方认证",
    "href": "http://stock.jrj.com.cn/2020/05/07221129612885.shtml",
    "datetime": "2020-05-07 22:11:08",
    "code": "000739"
  },
  {
    "title": "普洛药业抗抑郁药获美国仿制药批件",
    "href": "http://stock.jrj.com.cn/2020/04/30123129429908.shtml",
    "datetime": "2020-04-30 12:31:21",
    "code": "000739"
  },
  {
    "title": "午间公告：普洛药业向美国FDA申报仿制药补充申请获批",
    "href": "http://stock.jrj.com.cn/2020/04/30122229429831.shtml",
    "datetime": "2020-04-30 12:22:37",
    "code": "000739"
  },
  {
    "title": "普洛药业：子公司药品吲达帕胺片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/04/23163229359010.shtml",
    "datetime": "2020-04-23 16:32:00",
    "code": "000739"
  },
  {
    "title": "南极电商、伟星新材、普洛药业等公司被多家机构扎堆调研",
    "href": "http://stock.jrj.com.cn/2020/04/21084729335617.shtml",
    "datetime": "2020-04-21 08:47:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：二季度订单状况非常饱满",
    "href": "http://stock.jrj.com.cn/2020/04/20154029329432.shtml",
    "datetime": "2020-04-20 15:40:00",
    "code": "000739"
  },
  {
    "title": "普洛药业一季度净利同比增近四成",
    "href": "http://stock.jrj.com.cn/2020/04/17172529314272.shtml",
    "datetime": "2020-04-17 17:25:50",
    "code": "000739"
  },
  {
    "title": "普洛药业：一季度净利同比增长39.95%",
    "href": "http://stock.jrj.com.cn/2020/04/17155029313708.shtml",
    "datetime": "2020-04-17 15:50:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟使用8500万元闲置资金购买基金资管产品 进一步提高公司资金使用效率",
    "href": "http://stock.jrj.com.cn/2020/03/24164129095121.shtml",
    "datetime": "2020-03-24 16:41:24",
    "code": "000739"
  },
  {
    "title": "普洛药业：公司洛索洛芬钠原料药具备向日本市场供应资质",
    "href": "http://stock.jrj.com.cn/2020/03/13155829020417.shtml",
    "datetime": "2020-03-13 15:58:37",
    "code": "000739"
  },
  {
    "title": "普洛药业：洛索洛芬钠原料药具备向日本市场供应资质",
    "href": "http://stock.jrj.com.cn/2020/03/13154829020375.shtml",
    "datetime": "2020-03-13 15:48:40",
    "code": "000739"
  },
  {
    "title": "普洛药业：洛索洛芬钠原料药具备向日本市场供应资质",
    "href": "http://stock.jrj.com.cn/2020/03/13154429020369.shtml",
    "datetime": "2020-03-13 15:44:00",
    "code": "000739"
  },
  {
    "title": "公告精选：普洛药业等年报业绩同比大增；华脉科技三连板提示风险",
    "href": "http://stock.jrj.com.cn/2020/03/11220829003616.shtml",
    "datetime": "2020-03-11 22:08:00",
    "code": "000739"
  },
  {
    "title": "普洛药业拟为下属10家子公司及孙公司提供不超过人民币28.2亿元的融资担保",
    "href": "http://stock.jrj.com.cn/2020/03/11192229002901.shtml",
    "datetime": "2020-03-11 19:22:29",
    "code": "000739"
  },
  {
    "title": "普洛药业：2019年业绩同比增49% 营收及净利均创历史新高",
    "href": "http://stock.jrj.com.cn/2020/03/11170629001868.shtml",
    "datetime": "2020-03-11 17:06:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：2019年净利同比增长49% 拟10派1.65元",
    "href": "http://stock.jrj.com.cn/2020/03/11165529001825.shtml",
    "datetime": "2020-03-11 16:55:31",
    "code": "000739"
  },
  {
    "title": "普洛药业：捐赠“百士欣”乌苯美司胶囊10万盒支持疫情防控",
    "href": "http://stock.jrj.com.cn/2020/02/20161228862871.shtml",
    "datetime": "2020-02-20 16:12:33",
    "code": "000739"
  },
  {
    "title": "普洛药业捐赠“百士欣”乌苯美司胶囊10万盒 价值约1100万元",
    "href": "http://stock.jrj.com.cn/2020/02/20161128862864.shtml",
    "datetime": "2020-02-20 16:11:17",
    "code": "000739"
  },
  {
    "title": "普洛药业：捐赠“百士欣”乌苯美司胶囊10万盒 价值约1100万元",
    "href": "http://stock.jrj.com.cn/2020/02/20155828862835.shtml",
    "datetime": "2020-02-20 15:58:00",
    "code": "000739"
  },
  {
    "title": "普洛药业目前复工率接近90%",
    "href": "http://stock.jrj.com.cn/2020/02/13175928824506.shtml",
    "datetime": "2020-02-13 17:59:48",
    "code": "000739"
  },
  {
    "title": "普洛药业：截至目前公司复工率接近90%",
    "href": "http://stock.jrj.com.cn/2020/02/13172128824280.shtml",
    "datetime": "2020-02-13 17:21:26",
    "code": "000739"
  },
  {
    "title": "普洛药业：截至目前复工率接近90%",
    "href": "http://stock.jrj.com.cn/2020/02/13165628824176.shtml",
    "datetime": "2020-02-13 16:56:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]潍坊市委常委、组织部长刘国伟莅临山东汉兴医药检查指导疫情防控及安全生产工作",
    "href": "http://stock.jrj.com.cn/2020/02/12000029873158.shtml",
    "datetime": "2020-02-12 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]政协主席吴国升莅临巨泰药业检查指导疫情防控工作",
    "href": "http://stock.jrj.com.cn/2020/02/07000029873164.shtml",
    "datetime": "2020-02-07 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛抗疫 “粮草先行”——采购部奋战在抗疫一线",
    "href": "http://stock.jrj.com.cn/2020/02/06000029873163.shtml",
    "datetime": "2020-02-06 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]疫情挡不住“娘家人”的温情——普洛药业为鄂台温等地员工送温暖",
    "href": "http://stock.jrj.com.cn/2020/02/05000029873167.shtml",
    "datetime": "2020-02-05 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]市委书记傅显明莅临普洛药业检查指导疫情防控工作",
    "href": "http://stock.jrj.com.cn/2020/02/04000029873160.shtml",
    "datetime": "2020-02-04 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]横店镇政府为普洛药业送防疫知识培训",
    "href": "http://stock.jrj.com.cn/2020/01/31000029873155.shtml",
    "datetime": "2020-01-31 00:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业下属公司去年7月底至12月底收到政府补助2421万元",
    "href": "http://stock.jrj.com.cn/2020/01/18102828696267.shtml",
    "datetime": "2020-01-18 10:28:59",
    "code": "000739"
  },
  {
    "title": "普洛药业：子公司购买区块链应收款产品 将提高公司资金使用效率",
    "href": "http://stock.jrj.com.cn/2020/01/14173928675976.shtml",
    "datetime": "2020-01-14 17:39:25",
    "code": "000739"
  },
  {
    "title": "普洛药业：全资子公司购买5000万元浙商银行区块链应收款产品",
    "href": "http://stock.jrj.com.cn/2020/01/14162228675588.shtml",
    "datetime": "2020-01-14 16:22:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：子公司斥资5000万元购买浙商银行区块链应收款产品",
    "href": "http://stock.jrj.com.cn/2020/01/14155828675429.shtml",
    "datetime": "2020-01-14 15:58:52",
    "code": "000739"
  },
  {
    "title": "普洛药业子公司获得《兽药产品批准文号批件》",
    "href": "http://stock.jrj.com.cn/2020/01/09173128650705.shtml",
    "datetime": "2020-01-09 17:31:11",
    "code": "000739"
  },
  {
    "title": "普洛药业：“芬苯达唑”获兽药产品批准文号批件 进一步增强公司原料药CDMO业务",
    "href": "http://stock.jrj.com.cn/2020/01/09164028650432.shtml",
    "datetime": "2020-01-09 16:40:37",
    "code": "000739"
  },
  {
    "title": "普洛药业：子公司获得兽药产品批准文号批件",
    "href": "http://stock.jrj.com.cn/2020/01/09162528650372.shtml",
    "datetime": "2020-01-09 16:25:14",
    "code": "000739"
  },
  {
    "title": "普洛药业：预计2019年实现净利5.3亿元至5.8亿元",
    "href": "http://stock.jrj.com.cn/2020/01/09154028650166.shtml",
    "datetime": "2020-01-09 15:40:53",
    "code": "000739"
  },
  {
    "title": "普洛药业2019年预计盈利5.3亿元至5.8亿元 同比增长43%以上",
    "href": "http://stock.jrj.com.cn/2020/01/06164528631707.shtml",
    "datetime": "2020-01-06 16:45:58",
    "code": "000739"
  },
  {
    "title": "普洛药业：2019年预盈5.3亿元-5.8亿元 同比增长43%-57%",
    "href": "http://stock.jrj.com.cn/2020/01/06162428631624.shtml",
    "datetime": "2020-01-06 16:24:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/06162028631592.shtml",
    "datetime": "2020-01-06 16:20:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：2019年度净利同比预增43%-57%",
    "href": "http://stock.jrj.com.cn/2020/01/06155528631519.shtml",
    "datetime": "2020-01-06 15:55:08",
    "code": "000739"
  },
  {
    "title": "普洛药业：明年沙坦联苯预计要扩充20%产能",
    "href": "http://stock.jrj.com.cn/2019/12/26152728590720.shtml",
    "datetime": "2019-12-26 15:27:00",
    "code": "000739"
  },
  {
    "title": "普洛药业全资子公司通过日本PMDA认证",
    "href": "http://stock.jrj.com.cn/2019/12/11165128519927.shtml",
    "datetime": "2019-12-11 16:51:40",
    "code": "000739"
  },
  {
    "title": "普洛药业：头孢地尼原料药通过日本PMDA的GMP现场检查",
    "href": "http://stock.jrj.com.cn/2019/12/11155428519673.shtml",
    "datetime": "2019-12-11 15:54:38",
    "code": "000739"
  },
  {
    "title": "普洛药业：全资子公司得邦制药通过日本PMDA认证",
    "href": "http://stock.jrj.com.cn/2019/12/11154828519671.shtml",
    "datetime": "2019-12-11 15:48:00",
    "code": "000739"
  },
  {
    "title": "普洛药业与Bracco签署战略合作协议 深耕CDMO业务",
    "href": "http://stock.jrj.com.cn/2019/11/27204428459858.shtml",
    "datetime": "2019-11-27 20:44:23",
    "code": "000739"
  },
  {
    "title": "普洛药业：与全球影像诊断试剂供应的龙头企业Bracco集团子公司战略合作",
    "href": "http://stock.jrj.com.cn/2019/11/27164828458538.shtml",
    "datetime": "2019-11-27 16:48:24",
    "code": "000739"
  },
  {
    "title": "动物保健板块逆势走强 普洛药业大涨6%",
    "href": "http://stock.jrj.com.cn/2019/10/18113128266703.shtml",
    "datetime": "2019-10-18 11:31:00",
    "code": "000739"
  },
  {
    "title": "普洛药业靠降费和投资收益能否实现业绩高速增长",
    "href": "http://stock.jrj.com.cn/2019/10/18090928265379.shtml",
    "datetime": "2019-10-18 09:09:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：前三季度净利4.32亿元 同比增长58%",
    "href": "http://stock.jrj.com.cn/2019/10/17165628262179.shtml",
    "datetime": "2019-10-17 16:56:53",
    "code": "000739"
  },
  {
    "title": "普洛药业：前三季度净利同比增57.87%",
    "href": "http://stock.jrj.com.cn/2019/10/17162128262011.shtml",
    "datetime": "2019-10-17 16:21:57",
    "code": "000739"
  },
  {
    "title": "普洛药业前三季净利预增54%-59%",
    "href": "http://stock.jrj.com.cn/2019/09/26192528186216.shtml",
    "datetime": "2019-09-26 19:25:52",
    "code": "000739"
  },
  {
    "title": "普洛药业：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/09/26174028185296.shtml",
    "datetime": "2019-09-26 17:40:00",
    "code": "000739"
  },
  {
    "title": "普洛药业前三季度净利预增54%-59%",
    "href": "http://stock.jrj.com.cn/2019/09/26171728185180.shtml",
    "datetime": "2019-09-26 17:17:54",
    "code": "000739"
  },
  {
    "title": "普洛药业：前三季度净利预增54%-59%",
    "href": "http://stock.jrj.com.cn/2019/09/26171528185178.shtml",
    "datetime": "2019-09-26 17:15:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：前三季度净利同比预增54%-59%",
    "href": "http://stock.jrj.com.cn/2019/09/26164428185025.shtml",
    "datetime": "2019-09-26 16:44:59",
    "code": "000739"
  },
  {
    "title": "普洛药业左乙拉西坦片拟中选联盟地区集中采购",
    "href": "http://stock.jrj.com.cn/2019/09/24195428174253.shtml",
    "datetime": "2019-09-24 19:54:05",
    "code": "000739"
  },
  {
    "title": "普洛药业：公司左乙拉西坦片拟中选联盟地区集中采购",
    "href": "http://stock.jrj.com.cn/2019/09/24171328173416.shtml",
    "datetime": "2019-09-24 17:13:40",
    "code": "000739"
  },
  {
    "title": "普洛药业：左乙拉西坦片拟中选联盟地区集中采购",
    "href": "http://stock.jrj.com.cn/2019/09/24171028173409.shtml",
    "datetime": "2019-09-24 17:10:07",
    "code": "000739"
  },
  {
    "title": "普洛药业盐酸安非他酮缓释片获得美国FDA批准",
    "href": "http://stock.jrj.com.cn/2019/09/09091928107781.shtml",
    "datetime": "2019-09-09 09:19:20",
    "code": "000739"
  },
  {
    "title": "普洛药业：盐酸安非他酮缓释片获得美国FDA批准",
    "href": "http://stock.jrj.com.cn/2019/09/08163128105288.shtml",
    "datetime": "2019-09-08 16:31:18",
    "code": "000739"
  },
  {
    "title": "普洛药业：74个药品纳入2019版国家医保目录 退出产品3个",
    "href": "http://stock.jrj.com.cn/2019/08/22183128018104.shtml",
    "datetime": "2019-08-22 18:31:34",
    "code": "000739"
  },
  {
    "title": "普洛药业获得兽药生产许可证及证书",
    "href": "http://stock.jrj.com.cn/2019/08/19194527998935.shtml",
    "datetime": "2019-08-19 19:45:51",
    "code": "000739"
  },
  {
    "title": "普洛药业：子公司获得《兽药生产许可证》和《兽药GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/08/19165327996857.shtml",
    "datetime": "2019-08-19 16:53:40",
    "code": "000739"
  },
  {
    "title": "普洛药业全资子公司以自有闲置资金购买理财产品",
    "href": "http://stock.jrj.com.cn/2019/08/18183227992615.shtml",
    "datetime": "2019-08-18 18:32:08",
    "code": "000739"
  },
  {
    "title": "普洛药业：2019年半年度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/15175027982474.shtml",
    "datetime": "2019-08-15 17:50:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：上半年净利2.81亿元 同比增长51%",
    "href": "http://stock.jrj.com.cn/2019/08/15171427982006.shtml",
    "datetime": "2019-08-15 17:14:55",
    "code": "000739"
  },
  {
    "title": "普洛药业：上半年净利2.81亿元 同比增51%",
    "href": "http://stock.jrj.com.cn/2019/08/15170927982004.shtml",
    "datetime": "2019-08-15 17:09:00",
    "code": "000739"
  },
  {
    "title": "普洛药业全资子公司获得《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/08/07225027944445.shtml",
    "datetime": "2019-08-07 22:50:11",
    "code": "000739"
  },
  {
    "title": "普洛药业五家全资子公司合计获得政府奖励资金3351万元",
    "href": "http://stock.jrj.com.cn/2019/07/31081527906914.shtml",
    "datetime": "2019-07-31 08:15:34",
    "code": "000739"
  },
  {
    "title": "普洛药业：五家全资子公司获政府补助合计3351万元",
    "href": "http://stock.jrj.com.cn/2019/07/30164827904284.shtml",
    "datetime": "2019-07-30 16:48:00",
    "code": "000739"
  },
  {
    "title": "普洛药业上半年净利同比增长5成",
    "href": "http://stock.jrj.com.cn/2019/07/29183027900214.shtml",
    "datetime": "2019-07-29 18:30:18",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛药业技术创新再吹集结号",
    "href": "http://stock.jrj.com.cn/2019/07/13000027856691.shtml",
    "datetime": "2019-07-13 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛药业年中盘点: 业绩增长超预算 下半年首推创新",
    "href": "http://stock.jrj.com.cn/2019/07/11000027852763.shtml",
    "datetime": "2019-07-11 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]公司管理团队赴山东生产基地调研",
    "href": "http://stock.jrj.com.cn/2019/07/10000027856690.shtml",
    "datetime": "2019-07-10 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]省公安厅副厅长刘静一行来康裕制药检查指导",
    "href": "http://stock.jrj.com.cn/2019/07/04000027852762.shtml",
    "datetime": "2019-07-04 00:00:00",
    "code": "000739"
  },
  {
    "title": "[鲁抗医药]普洛药业—鲁抗医药进行高层战略合作交流",
    "href": "http://stock.jrj.com.cn/2019/07/04000027799279.shtml",
    "datetime": "2019-07-04 00:00:00",
    "code": "000739"
  },
  {
    "title": "[鲁抗医药]普洛药业—鲁抗医药进行高层战略合作交流",
    "href": "http://stock.jrj.com.cn/2019/07/04000031601363.shtml",
    "datetime": "2019-07-04 00:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/06/25200027754440.shtml",
    "datetime": "2019-06-25 20:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：上半年净利预增39%-50%",
    "href": "http://stock.jrj.com.cn/2019/06/25155327753162.shtml",
    "datetime": "2019-06-25 15:53:16",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛药业APF1804项目 荣获2019年东阳市第四届青年创业创新大赛特别奖",
    "href": "http://stock.jrj.com.cn/2019/06/23000027852760.shtml",
    "datetime": "2019-06-23 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛药业参展CPhl",
    "href": "http://stock.jrj.com.cn/2019/06/20000027852761.shtml",
    "datetime": "2019-06-20 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]湖北宜昌政府团参观杭州药物研究院",
    "href": "http://stock.jrj.com.cn/2019/06/18000027852759.shtml",
    "datetime": "2019-06-18 00:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业扣非净利三年增近九成 员工持股计划完成",
    "href": "http://stock.jrj.com.cn/2019/06/12072027692157.shtml",
    "datetime": "2019-06-12 07:20:26",
    "code": "000739"
  },
  {
    "title": "普洛药业第一期员工持股计划完成股票购买",
    "href": "http://stock.jrj.com.cn/2019/06/11214827688218.shtml",
    "datetime": "2019-06-11 21:48:23",
    "code": "000739"
  },
  {
    "title": "普洛药业控股股东横店控股及其全资公司累计增持1596万股",
    "href": "http://stock.jrj.com.cn/2019/05/23072927610156.shtml",
    "datetime": "2019-05-23 07:29:46",
    "code": "000739"
  },
  {
    "title": "普洛药业拟推3.5亿元员工持股计划",
    "href": "http://stock.jrj.com.cn/2019/05/10212027555603.shtml",
    "datetime": "2019-05-10 21:20:25",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟推3.5亿元员工持股计划",
    "href": "http://stock.jrj.com.cn/2019/05/10163927554529.shtml",
    "datetime": "2019-05-10 16:39:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟推总额不超3.5亿元持股计划",
    "href": "http://stock.jrj.com.cn/2019/05/10163427554474.shtml",
    "datetime": "2019-05-10 16:34:47",
    "code": "000739"
  },
  {
    "title": "普洛药业：一季度净利1.1亿元 同比增长65%",
    "href": "http://stock.jrj.com.cn/2019/04/22161827454562.shtml",
    "datetime": "2019-04-22 16:18:28",
    "code": "000739"
  },
  {
    "title": "[普洛药业]做精原料正当时 普洛药业召开原料药战略发展规划会议",
    "href": "http://stock.jrj.com.cn/2019/04/03000027319253.shtml",
    "datetime": "2019-04-03 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]你知道吗横马有个天立威",
    "href": "http://stock.jrj.com.cn/2019/04/01000027319252.shtml",
    "datetime": "2019-04-01 00:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/03/25180027230531.shtml",
    "datetime": "2019-03-25 18:00:03",
    "code": "000739"
  },
  {
    "title": "普洛药业：一季度净利预增49%-79%",
    "href": "http://stock.jrj.com.cn/2019/03/25170627229908.shtml",
    "datetime": "2019-03-25 17:06:16",
    "code": "000739"
  },
  {
    "title": "普洛药业：2018年净利同比增44% 拟10派1.1元",
    "href": "http://stock.jrj.com.cn/2019/03/08155327136786.shtml",
    "datetime": "2019-03-08 15:53:10",
    "code": "000739"
  },
  {
    "title": "普洛药业：2018年度净利预增36%—52%",
    "href": "http://stock.jrj.com.cn/hotstock/2019/01/04075926850910.shtml",
    "datetime": "2019-01-04 07:59:55",
    "code": "000739"
  },
  {
    "title": "普洛药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/03165026847699.shtml",
    "datetime": "2019-01-03 16:50:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛药业亮相80届药交会",
    "href": "http://stock.jrj.com.cn/2018/12/25000026813160.shtml",
    "datetime": "2018-12-25 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛药业与浙江工商大学签署产学研合作协议",
    "href": "http://stock.jrj.com.cn/2018/12/25000026813164.shtml",
    "datetime": "2018-12-25 00:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：API产能基本全满 主要品种供不应求",
    "href": "http://stock.jrj.com.cn/2018/11/08191325319962.shtml",
    "datetime": "2018-11-08 19:13:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]福州大维医药来我公司参观考察",
    "href": "http://stock.jrj.com.cn/2018/11/02000026813162.shtml",
    "datetime": "2018-11-02 00:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：2018年前三季度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/25164025259140.shtml",
    "datetime": "2018-10-25 16:40:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：三季度净利同比增162%",
    "href": "http://stock.jrj.com.cn/2018/10/25161425259000.shtml",
    "datetime": "2018-10-25 16:14:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：前三季度净利预增63%-69%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/10075925179834.shtml",
    "datetime": "2018-10-10 07:59:53",
    "code": "000739"
  },
  {
    "title": "普洛药业：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/09171025177609.shtml",
    "datetime": "2018-10-09 17:10:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：前三季度净利同比预增63%-69%",
    "href": "http://stock.jrj.com.cn/2018/10/09165025177541.shtml",
    "datetime": "2018-10-09 16:50:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟1750万元转让康裕医药100%股权",
    "href": "http://stock.jrj.com.cn/hotstock/2018/09/12075925079734.shtml",
    "datetime": "2018-09-12 07:59:57",
    "code": "000739"
  },
  {
    "title": "普洛药业拟出售康裕医药100%股权 推出医药流通领域",
    "href": "http://stock.jrj.com.cn/2018/09/11175225077629.shtml",
    "datetime": "2018-09-11 17:52:37",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟转让康裕医药100%股权",
    "href": "http://stock.jrj.com.cn/2018/09/11171025077391.shtml",
    "datetime": "2018-09-11 17:10:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：泰乐菌素产能今年预计能达到150-200吨",
    "href": "http://stock.jrj.com.cn/2018/08/31144525031764.shtml",
    "datetime": "2018-08-31 14:45:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：泰乐菌素项目处于中试放大阶段",
    "href": "http://stock.jrj.com.cn/2018/08/23144024991278.shtml",
    "datetime": "2018-08-23 14:40:00",
    "code": "000739"
  },
  {
    "title": "仿制药市场大调整：一致性评价定生死",
    "href": "http://stock.jrj.com.cn/2018/08/17010724963832.shtml",
    "datetime": "2018-08-17 01:07:21",
    "code": "000739"
  },
  {
    "title": "普洛药业：业绩符合预期 盈利改善拐点开始",
    "href": "http://stock.jrj.com.cn/2018/08/08094124922969.shtml",
    "datetime": "2018-08-08 09:41:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：上半年净利1.86亿元 同比增长44%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/08075924922410.shtml",
    "datetime": "2018-08-08 07:59:59",
    "code": "000739"
  },
  {
    "title": "普洛药业：上半年净利同比增逾四成",
    "href": "http://stock.jrj.com.cn/2018/08/07181024918072.shtml",
    "datetime": "2018-08-07 18:10:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]校企联谊谋发展 合作双赢谱新篇",
    "href": "http://stock.jrj.com.cn/2018/07/13000026813165.shtml",
    "datetime": "2018-07-13 00:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：上半年净利1.85亿元 同比增逾4成",
    "href": "http://stock.jrj.com.cn/hotstock/2018/07/10075924793127.shtml",
    "datetime": "2018-07-10 07:59:50",
    "code": "000739"
  },
  {
    "title": "普洛药业：上半年净利同比增逾4成",
    "href": "http://stock.jrj.com.cn/2018/07/09165024788311.shtml",
    "datetime": "2018-07-09 16:50:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：四家控股子公司合计获得1997万元政府补助",
    "href": "http://stock.jrj.com.cn/2018/06/20160024705044.shtml",
    "datetime": "2018-06-20 16:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业控股股东增持1%股份",
    "href": "http://stock.jrj.com.cn/2018/06/04203024635599.shtml",
    "datetime": "2018-06-04 20:30:31",
    "code": "000739"
  },
  {
    "title": "普洛药业：控股股东增持逾1178万股",
    "href": "http://stock.jrj.com.cn/2018/06/04180524635162.shtml",
    "datetime": "2018-06-04 18:05:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]学习讲话坚定信心 凝聚共识谋划发展",
    "href": "http://stock.jrj.com.cn/2018/05/25000026813161.shtml",
    "datetime": "2018-05-25 00:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟投资设立杭州优胜美特药物研究院",
    "href": "http://stock.jrj.com.cn/hotstock/2018/05/23075924577239.shtml",
    "datetime": "2018-05-23 07:59:59",
    "code": "000739"
  },
  {
    "title": "周末重要增减持公告:普洛药业控股股东小幅增持至50%",
    "href": "http://stock.jrj.com.cn/2018/05/21081924566044.shtml",
    "datetime": "2018-05-21 08:19:00",
    "code": "000739"
  },
  {
    "title": "普洛药业控股股东增持400万股 占比0.344％",
    "href": "http://stock.jrj.com.cn/2018/05/18174724560483.shtml",
    "datetime": "2018-05-18 17:47:26",
    "code": "000739"
  },
  {
    "title": "[普洛药业]【快乐工作】普洛药业三项目通过中央预算内投资项目验收",
    "href": "http://stock.jrj.com.cn/2018/04/26000026813163.shtml",
    "datetime": "2018-04-26 00:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业：2017年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2018/03/09175024218759.shtml",
    "datetime": "2018-03-09 17:50:00",
    "code": "000739"
  },
  {
    "title": "普洛药业年报业绩略降 拟10派0.65元",
    "href": "http://stock.jrj.com.cn/2018/03/09164824218449.shtml",
    "datetime": "2018-03-09 16:48:48",
    "code": "000739"
  },
  {
    "title": "普洛药业：拟对子公司康裕制药增资1.22亿元",
    "href": "http://stock.jrj.com.cn/hotstock/2017/12/05075923740524.shtml",
    "datetime": "2017-12-05 07:59:59",
    "code": "000739"
  },
  {
    "title": "“横店系”资金独揽定增 普洛药业的春天在哪里？",
    "href": "http://stock.jrj.com.cn/2017/11/28111023706246.shtml",
    "datetime": "2017-11-28 11:10:26",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛康裕举办五四青年节户外拓展活动",
    "href": "http://stock.jrj.com.cn/2017/08/23000023944514.shtml",
    "datetime": "2017-08-23 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛康裕党委举办“红色朗读者”朗诵大赛",
    "href": "http://stock.jrj.com.cn/2017/08/23000024101365.shtml",
    "datetime": "2017-08-23 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛康裕连续11年荣获全国安康杯竞赛优胜单位",
    "href": "http://stock.jrj.com.cn/2017/07/12000023944510.shtml",
    "datetime": "2017-07-12 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛康裕党委组织党员开展入党宣誓活动",
    "href": "http://stock.jrj.com.cn/2017/06/25000023944511.shtml",
    "datetime": "2017-06-25 00:00:00",
    "code": "000739"
  },
  {
    "title": "[普洛药业]普洛康裕举办庆“三八”拔河比赛",
    "href": "http://stock.jrj.com.cn/2017/05/26000023944512.shtml",
    "datetime": "2017-05-26 00:00:00",
    "code": "000739"
  },
  {
    "title": "普洛药业控股股东增持1%股份",
    "href": "http://stock.jrj.com.cn/2017/05/14184122475206.shtml",
    "datetime": "2017-05-14 18:41:50",
    "code": "000739"
  },
  {
    "title": "普洛药业再获管理层持股平台增持1835万股",
    "href": "http://stock.jrj.com.cn/2016/07/21165521217841.shtml",
    "datetime": "2016-07-21 16:55:50",
    "code": "000739"
  },
  {
    "title": "普洛药业：与中国农发重点建设基金投资有限公司合作",
    "href": "http://stock.jrj.com.cn/hotstock/2016/06/21075921092588.shtml",
    "datetime": "2016-06-21 07:59:58",
    "code": "000739"
  },
  {
    "title": "普洛药业将于3月25日提前披露年报",
    "href": "http://stock.jrj.com.cn/2016/03/23114220727896.shtml",
    "datetime": "2016-03-23 11:42:54",
    "code": "000739"
  },
  {
    "title": "普洛药业：两子公司吸收合并 对股价影响不大",
    "href": "http://stock.jrj.com.cn/2016/01/21161520468075.shtml",
    "datetime": "2016-01-21 16:15:00",
    "code": "000739"
  },
  {
    "title": "上市公司公告牌：普洛药业子公司获得政府补贴",
    "href": "http://stock.jrj.com.cn/2015/01/15144918707571.shtml",
    "datetime": "2015-01-15 14:49:48",
    "code": "000739"
  },
  {
    "title": "普洛药业：获得政府专项补贴资金500万元",
    "href": "http://stock.jrj.com.cn/hotstock/2015/01/15075918704703.shtml",
    "datetime": "2015-01-15 07:59:50",
    "code": "000739"
  },
  {
    "title": "普洛药业：非公开发行股票获中国证监会发审会审核通过",
    "href": "http://stock.jrj.com.cn/hotstock/2014/07/14075917592054.shtml",
    "datetime": "2014-07-14 07:59:59",
    "code": "000739"
  },
  {
    "title": "收盘：普洛药业跌 4.22%报 7.95元 换手 4.7%",
    "href": "http://stock.jrj.com.cn/2014/04/21153817081403.shtml",
    "datetime": "2014-04-21 15:38:40",
    "code": "000739"
  },
  {
    "title": "普洛药业子公司获政府补助5000万元",
    "href": "http://stock.jrj.com.cn/2013/12/26030116395104.shtml",
    "datetime": "2013-12-26 03:01:01",
    "code": "000739"
  },
  {
    "title": "普洛药业：4300万元受让58个抗感染类药品技术",
    "href": "http://stock.jrj.com.cn/hotstock/2013/08/05163015635341.shtml",
    "datetime": "2013-08-05 16:30:41",
    "code": "000739"
  },
  {
    "title": "普洛药业：2013年半年度业绩预告",
    "href": "http://stock.jrj.com.cn/2013/07/11162715517173.shtml",
    "datetime": "2013-07-11 16:27:17",
    "code": "000739"
  },
  {
    "title": "普洛药业：志存高远 规划清晰",
    "href": "http://stock.jrj.com.cn/hotstock/2013/06/04143815368121.shtml",
    "datetime": "2013-06-04 14:38:55",
    "code": "000739"
  },
  {
    "title": "普洛股份重大资产重组过会 明起复牌",
    "href": "http://stock.jrj.com.cn/2012/12/13183214818639.shtml",
    "datetime": "2012-12-13 18:32:47",
    "code": "000739"
  },
  {
    "title": "普洛股份预计三季度净利大增4-5倍",
    "href": "http://stock.jrj.com.cn/2012/10/12184214507016.shtml",
    "datetime": "2012-10-12 18:42:31",
    "code": "000739"
  },
  {
    "title": "普洛股份子公司再获政府投资",
    "href": "http://stock.jrj.com.cn/2012/08/08062214047911.shtml",
    "datetime": "2012-08-08 06:22:49",
    "code": "000739"
  },
  {
    "title": "普洛股份预计上半年扭亏为盈",
    "href": "http://stock.jrj.com.cn/2012/07/12204313778249.shtml",
    "datetime": "2012-07-12 20:43:13",
    "code": "000739"
  },
  {
    "title": "普洛股份遭“无本万利”质疑",
    "href": "http://stock.jrj.com.cn/2012/03/02092312390257.shtml",
    "datetime": "2012-03-02 09:23:23",
    "code": "000739"
  },
  {
    "title": "普洛股份增发迷雾：进出口资产竟增值7倍",
    "href": "http://stock.jrj.com.cn/2012/02/25034412339406.shtml",
    "datetime": "2012-02-25 03:44:39",
    "code": "000739"
  },
  {
    "title": "主力资金疑借利好出货 普洛股份短期股价面临下行",
    "href": "http://stock.jrj.com.cn/2012/02/14084012237409.shtml",
    "datetime": "2012-02-14 08:40:33",
    "code": "000739"
  },
  {
    "title": "普洛股份：拟购横店控股旗下医药资产",
    "href": "http://stock.jrj.com.cn/2012/02/13074712225907.shtml",
    "datetime": "2012-02-13 07:47:10",
    "code": "000739"
  },
  {
    "title": "普洛股份称正在筹划重大事项",
    "href": "http://stock.jrj.com.cn/2011/11/09193111522751.shtml",
    "datetime": "2011-11-09 19:31:23",
    "code": "000739"
  },
  {
    "title": "普洛股份下午起临时停牌 因发生重大事项",
    "href": "http://stock.jrj.com.cn/2011/11/09141111520475.shtml",
    "datetime": "2011-11-09 14:11:21",
    "code": "000739"
  },
  {
    "title": "普洛股份：发生重大事项 午后临时停牌",
    "href": "http://stock.jrj.com.cn/2011/11/09131711520090.shtml",
    "datetime": "2011-11-09 13:17:00",
    "code": "000739"
  },
  {
    "title": "普洛股份关联交易整改遭质疑 涉嫌利润转移",
    "href": "http://stock.jrj.com.cn/2011/07/01112010343339.shtml",
    "datetime": "2011-07-01 11:20:55",
    "code": "000739"
  },
  {
    "title": "普洛股份关联交易整改遭质疑",
    "href": "http://stock.jrj.com.cn/2011/07/01101710342699.shtml",
    "datetime": "2011-07-01 10:17:36",
    "code": "000739"
  },
  {
    "title": "普洛股份承诺减少关联交易",
    "href": "http://stock.jrj.com.cn/2011/06/17141610233477.shtml",
    "datetime": "2011-06-17 14:16:02",
    "code": "000739"
  }
]